Georgia Retina is a clinical research site located in Marietta, Georgia, United States 30060.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
Georgia Retina has participated in 10 clinical trials with 4 currently active.
Therapeutic areas: Diabetic Macular Edema, Geographic Atrophy, Neovascular Age-related Macular Degeneration.
Sponsors: Hoffmann-La Roche, Apellis Pharmaceuticals, Inc., Notal Vision Inc..
Trust Score: 76/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Georgia Retina has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Georgia Retina has 10 clinical trials on record, with 4 currently active. Their work covers Diabetic Macular Edema, Geographic Atrophy, Neovascular Age-related Macular Degeneration.
Georgia Retina has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.